Expanding access to long-acting HIV therapy in low-income and middle-income countries
The global HIV response stands on the threshold of a defining moment. Scientific breakthroughs have ushered in long-acting antiretroviral therapy (ART), which has redefined how HIV can be managed. Injectable formulations, such as cabotegravir–rilpivirine administered every 2 months, have shown high efficacy, safety, and preference across diverse populations and age groups.
 |
Dr. Charles OlaroBoard Member, JCRC |
Dr. Charles Olaro is the Director General Health services at the Ministry of Health. He is a Senior Consultant Surgeon, has Masters Degree in Surgery, Masters in Health Services Management and Masters in Business Administration (MBA).
He is an Honorary Fellow, College of Surgeons of East Central and Southern Africa (COSECSA) and recipient of 2014 International Visitors Leadership Program on Global Women’s Health Issues under the United States Department of State Bureau of Educational and Cultural Affairs.
Dr. Olaro is the author of a book, Service Delivery Standards in Public Health Facilities in Uganda Paperback, published in 2019 by Lambert Academic Publishing. He has over 30 years of experience working in the Public and Private sector, working within Health services.
